Huillca-Briceño A

Language: Spanish
References: 25
Page: 189-198
PDF size: 149.22 Kb.

ABSTRACT

Introduction: the prevalence of diabetes mellitus is estimated to be 7% in Peru. One in 100 of these cases is gestational type. A previous report said gestetional diabetes mellitus affects 4% of Peruvian pregnant.
Objectives: identify risk factors for gestational diabetes mellitus (GDM).
Methods: acase-control study was performed in Alberto Sabogal Hospital, collecting medical records from 2009 to 2014. 84 cases and 336 controls were included. A case was defined as a pregnant women diagnosed with GDM by an oral glucose tolerance test (OGTT) after an abnormal fasting glucose and control was defined as a pregnant women without GDM indicative values. The study outcome was GDM. The variables of interest were multiparity, previous cesarean section, abortions, newborn with the greatest weight. Logistic regression were used to calculate the odds ratio (OR) and a confidence interval of 95% (IC95%).
Conclusions: this study describes the association of gestational diabetes mellitus with some obstetrical history as multiparity, history of caesarean sections and / or abortions. For this reason, it is recommended to implement prevention and identification of pregnant women with warning signs of gestational diabetes mellitus for early diagnosis and monitoring of these patients in the postpartum period.

REFERENCES

1. Seclen SN, Rosas ME, Arias AJ, Huayta E, Medina CA. Prevalence of diabetes and impaired fasting glucose in Peru: report from PERUDIAB, a national urban population based longitudinal study. BMJ Open Diabetes Research and Care. 2015;3:e000110.

2. Revilla L. Situación de la vigilancia de diabetes en el Perú, al I semestre de 2013. 2013;22(39):825-8.

3. EsSALUD. Seguro Social de Salud del Perú [Internet]. Disponible en: http://www.essalud.gob.pe/2012/11/14/diabetes-mellitus-afecta-al-4-degestantes- en-el-peru/

4. Jafari-Shobeiri M, Ghojazadeh M, Azami-Aghdash S, Naghavi-Behzad M, Piri R, Pourali-Akbar Y, et al. Prevalence and Risk Factors of Gestational Diabetes in Iran: A Systematic Review and Meta-Analysis. Iran J Public Health. 2015;44(8):1036-44.

5. American Diabetes Association. Gestational Diabetes Mellitus. Definition, detection, and diagnosis. Diabetes care. 2003;26(1):S103-S5.

6. The HAPO. Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes. N Engl J Med. 2008;358:1991-2002.

7. Kampmann U, Madsen LR, Skajaa GO, Iversen DS, Moeller N, Ovesen P. Gestational diabetes: A clinical update. World J Diabetes. 2015;6(8):1065-72.

8. Wendland EM, Torloni MR, Falavigna M, Trujillo J, Dode MA, Campos MA, et al. Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy and Childbirth. 2012;12:23.

9. Bener A, Saleh N, Al-Hamaq A. Prevalence of gestational diabetes and associated maternal and neonatal complications in a fast-developing community: global comparisons. International Journal of Women's Health. 2011;3:367-73.

10. Schmidt M, Duncan BB, Reichelt AJ, Branchtein L, Matos MC, Costa e Forti A, et al. Gestational Diabetes Mellitus Diagnosed With a 2-h 75-g Oral Glucose Tolerance Test and Adverse Pregnancy Outcomes. Diabetes Care. 2001;24(7):1151-5.

11. Ylave G, Gutarra RB. Diabetes mellitus gestacional. Experiencia en el Hospital militar central. Rev Per Ginecol Obstet. 2009;55:135-42.

12. Di Cianni G, Volpe L, Lencioni C, Miccoli R, Cuccuru I, Ghio A, et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract. 2003;62(2):131-7.

13. Khan R, Ali K, Khan Z. Socio-demographic risk factors of Gestational Diabetes Mellitus. Pak J Med Sci. 2013;29(3):843-6.

14. Keshavarz M, Cheung NW, Babaee GR, Moghadam HK, Ajami ME, Shariati M. Gestational diabetes in Iran: incidence, risk factors and pregnancy outcomes. Diabetes Res Clin Pract. 2005;69:279-86.

15. Campo-Campo MN, Posada-Estrada G, Betancur-Bermúdez LC, Jaramillo- Quiceno DM. Factores de riesgo para diabetes gestacional en población obstétrica en tres instituciones de Medellín, Colombia. Estudio de casos y controles. Rev Colomb Obstet Ginecol. 2012;63:114-8.

16. Yves J, Katrien V, Sanne V. A Systematic Review of Grand Multiparity. Current Women's Health Reviews. 2006;2(1):25-32.

17. ESSALUD. Seguro Social de Salud del Perú [Internet]. Estadística Institucional. EsSalud en Cifras: Informativo Mensual 2013. [citado 2015 jul 12]. Disponible en: http://www.essalud.gob.pe/estadistica-institucional/

18. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes care. 2013;36(1):67-74.

19. American Diabetes Association. Standards of Medical Care in Diabetes-2013. Diabetes Care. 2013;36(1):11-66.

20. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115(3):485-91.

21. Seghieri G, De Bellis A, Anichini R, Alviggi L, Franconi F, Breschi MC. Does parity increase insulin resistance during pregnancy? DiabeticMed. 2005;22(11):1574-80.

22. Anna V, van der Ploeg HP, Cheung NW, Huxley RR, Bauman AE. Sociodemographic correlates of the increasing trend in prevalence of gestational diabetes mellitus in a large population of women between 1995 and 2005. Diabetes Care. 2008;31(12):2288-93.

23. Santillana E, Ávila F. Infertilidad e insulinorresistencia. Arch Inv Mat Inf. 2009;I(3):118-22.

24. Soheilykhah S, Mogibian M, Rahimi-Saghand S, Rashidi M, Soheilykhah S, Piroz M. Incidence of gestational diabetes mellitus in pregnant women. Iranian Journal of Reproductive Medicine. 2010;8(1):24-8.

25. Buchanan TA, Xiang AH, Page KA. Gestational Diabetes Mellitus: Risks and Management during and after Pregnancy. Nat Rev Endocrinol. 2012;8(11):639-49.